• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用绿色荧光蛋白融合技术和流式细胞术优化重组肿瘤坏死因子α的生产。

Optimisation of recombinant TNFα production in using GFP fusions and flow cytometry.

作者信息

Zulkifly Nurul Asma Hasliza, Selas Castiñeiras Tania, Overton Tim W

机构信息

School of Chemical Engineering and Institute of Microbiology and Infection, The University of Birmingham, Birmingham, United Kingdom.

Cobra Biologics, Keele, United Kingdom.

出版信息

Front Bioeng Biotechnol. 2023 Aug 2;11:1171823. doi: 10.3389/fbioe.2023.1171823. eCollection 2023.

DOI:10.3389/fbioe.2023.1171823
PMID:37600304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10433901/
Abstract

is commonly used industrially to manufacture recombinant proteins for biopharmaceutical applications, as well as in academic and industrial settings for R&D purposes. Optimisation of recombinant protein production remains problematic as many proteins are difficult to make, and process conditions must be optimised for each individual protein. An approach to accelerate process development is the use of a green fluorescent protein (GFP) fusions, which can be used to rapidly and simply measure the quantity and folding state of the protein of interest. In this study, we used GFP fusions to optimise production of recombinant human protein tumour necrosis factor (rhTNFα) using a T7 expression system. Flow cytometry was used to measure fluorescence and cell viability on a single cell level to determine culture heterogeneity. Fluorescence measurements were found to be comparable to data generated by subcellular fractionation and SDS-PAGE, a far more time-intensive technique. We compared production of rhTNFα-GFP with that of GFP alone to determine the impact of rhTNFα on expression levels. Optimised shakeflask conditions were then transferred to fed-batch high cell density bioreactor cultures. Finally, the expression of GFP from a p expression vector was compared to the T7 system. We highlight the utility of GFP fusions and flow cytometry for rapid process development.

摘要

在工业上通常用于生产生物制药应用的重组蛋白,以及在学术和工业环境中用于研发目的。重组蛋白生产的优化仍然存在问题,因为许多蛋白质难以制备,并且必须针对每种蛋白质优化工艺条件。加速工艺开发的一种方法是使用绿色荧光蛋白(GFP)融合蛋白,它可用于快速简单地测量目标蛋白的数量和折叠状态。在本研究中,我们使用GFP融合蛋白通过T7表达系统优化重组人蛋白肿瘤坏死因子(rhTNFα)的生产。流式细胞术用于在单细胞水平上测量荧光和细胞活力,以确定培养物的异质性。发现荧光测量结果与亚细胞分级分离和SDS-PAGE产生的数据相当,而后者是一种耗时得多的技术。我们比较了rhTNFα-GFP与单独GFP的生产情况,以确定rhTNFα对表达水平的影响。然后将优化的摇瓶条件转移到补料分批高细胞密度生物反应器培养中。最后,将p表达载体中GFP的表达与T7系统进行了比较。我们强调了GFP融合蛋白和流式细胞术在快速工艺开发中的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8109/10433901/e74ab65c0e91/fbioe-11-1171823-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8109/10433901/3a344bbbbca3/fbioe-11-1171823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8109/10433901/c33bdaeee7ef/fbioe-11-1171823-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8109/10433901/1fc7c92be2b0/fbioe-11-1171823-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8109/10433901/74ea6b772ec6/fbioe-11-1171823-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8109/10433901/1874bdf5716c/fbioe-11-1171823-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8109/10433901/9ebfce062328/fbioe-11-1171823-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8109/10433901/e74ab65c0e91/fbioe-11-1171823-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8109/10433901/3a344bbbbca3/fbioe-11-1171823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8109/10433901/c33bdaeee7ef/fbioe-11-1171823-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8109/10433901/1fc7c92be2b0/fbioe-11-1171823-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8109/10433901/74ea6b772ec6/fbioe-11-1171823-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8109/10433901/1874bdf5716c/fbioe-11-1171823-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8109/10433901/9ebfce062328/fbioe-11-1171823-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8109/10433901/e74ab65c0e91/fbioe-11-1171823-g007.jpg

相似文献

1
Optimisation of recombinant TNFα production in using GFP fusions and flow cytometry.利用绿色荧光蛋白融合技术和流式细胞术优化重组肿瘤坏死因子α的生产。
Front Bioeng Biotechnol. 2023 Aug 2;11:1171823. doi: 10.3389/fbioe.2023.1171823. eCollection 2023.
2
Use of a stress-minimisation paradigm in high cell density fed-batch Escherichia coli fermentations to optimise recombinant protein production.在高密度补料分批大肠杆菌发酵中使用应激最小化范式来优化重组蛋白生产。
J Ind Microbiol Biotechnol. 2014 Sep;41(9):1391-404. doi: 10.1007/s10295-014-1489-1. Epub 2014 Jul 24.
3
Optimizing host cell physiology and stress avoidance for the production of recombinant human tumour necrosis factor α in Escherichia coli.优化宿主细胞生理和避免应激反应以在大肠杆菌中生产重组人肿瘤坏死因子α。
Microbiology (Reading). 2018 Apr;164(4):440-452. doi: 10.1099/mic.0.000622. Epub 2018 Feb 14.
4
High-yield export of a native heterologous protein to the periplasm by the tat translocation pathway in Escherichia coli.通过tat 转运途径将天然异源蛋白高效输出到大肠杆菌周质腔。
Biotechnol Bioeng. 2012 Oct;109(10):2533-42. doi: 10.1002/bit.24535. Epub 2012 May 11.
5
Evaluation of the GFP signal and its aptitude for novel on-line monitoring strategies of recombinant fermentation processes.绿色荧光蛋白(GFP)信号评估及其在重组发酵过程新型在线监测策略中的适用性。
J Biotechnol. 2004 Mar 4;108(2):115-25. doi: 10.1016/j.jbiotec.2003.11.007.
6
Heterologous production of active ribonuclease inhibitor in Escherichia coli by redox state control and chaperonin coexpression.通过氧化还原状态控制和伴侣蛋白共表达在大肠杆菌中异源生产活性核糖核酸酶抑制剂。
Microb Cell Fact. 2011 Aug 8;10:65. doi: 10.1186/1475-2859-10-65.
7
High-level secretion of a recombinant protein to the culture medium with a Bacillus subtilis twin-arginine translocation system in Escherichia coli.在大肠杆菌中利用枯草芽孢杆菌双精氨酸转运系统向培养基中高水平分泌重组蛋白。
FEBS J. 2013 Aug;280(16):3810-21. doi: 10.1111/febs.12376. Epub 2013 Jul 5.
8
Reduction of acetate accumulation in Escherichia coli cultures for increased recombinant protein production.减少大肠杆菌培养物中乙酸盐的积累以提高重组蛋白产量。
Metab Eng. 2008 Mar;10(2):97-108. doi: 10.1016/j.ymben.2007.10.003. Epub 2007 Nov 17.
9
Use of GFP fusions for the isolation of Escherichia coli strains for improved production of different target recombinant proteins.利用 GFP 融合蛋白筛选提高不同目的重组蛋白产量的大肠杆菌菌株
J Biotechnol. 2011 Oct 20;156(1):11-21. doi: 10.1016/j.jbiotec.2011.08.016. Epub 2011 Aug 22.
10
Expression of green fluorescent protein fused to magnetosome proteins in microaerophilic magnetotactic bacteria.微需氧趋磁细菌中与磁小体蛋白融合的绿色荧光蛋白的表达
Appl Environ Microbiol. 2008 Aug;74(15):4944-53. doi: 10.1128/AEM.00231-08. Epub 2008 Jun 6.

引用本文的文献

1
A galactose-based auto-expression system improves T7-inducible protein production in Escherichia coli.一种基于半乳糖的自动表达系统可提高大肠杆菌中T7诱导型蛋白的产量。
Sci Rep. 2025 Mar 15;15(1):8936. doi: 10.1038/s41598-025-91954-5.
2
Comparative Approaches for Quantification of Product Yield in a Model Recombinant Green Fluorescent Protein Expressed in .在……中表达的模型重组绿色荧光蛋白中产物产量定量的比较方法
bioRxiv. 2024 Jun 24:2024.06.24.600411. doi: 10.1101/2024.06.24.600411.

本文引用的文献

1
New vectors for urea-inducible recombinant protein production.用于尿素诱导重组蛋白生产的新型载体。
N Biotechnol. 2022 Dec 25;72:89-96. doi: 10.1016/j.nbt.2022.10.003. Epub 2022 Oct 20.
2
Inexpensive protein overexpression driven by the NarL transcription activator protein.由NarL转录激活蛋白驱动的廉价蛋白质过表达。
Biotechnol Bioeng. 2022 Jun;119(6):1614-1623. doi: 10.1002/bit.28071. Epub 2022 Mar 6.
3
The PAR promoter expression system: Modified lac promoters for controlled recombinant protein production in Escherichia coli.
PAR 启动子表达系统:改良的 lac 启动子,用于控制大肠杆菌中重组蛋白的生产。
N Biotechnol. 2021 Sep 25;64:1-8. doi: 10.1016/j.nbt.2021.05.001. Epub 2021 May 10.
4
Use of a design of experiments approach to optimise production of a recombinant antibody fragment in the periplasm of Escherichia coli: selection of signal peptide and optimal growth conditions.采用实验设计方法优化重组抗体片段在大肠杆菌周质中的生产:信号肽的选择和最佳生长条件
AMB Express. 2019 Jan 7;9(1):5. doi: 10.1186/s13568-018-0727-8.
5
Biopharmaceutical benchmarks 2018.2018年生物制药基准
Nat Biotechnol. 2018 Dec 6;36(12):1136-1145. doi: 10.1038/nbt.4305.
6
Development of a generic β-lactamase screening system for improved signal peptides for periplasmic targeting of recombinant proteins in Escherichia coli.开发一种通用的β-内酰胺酶筛选系统,以改善重组蛋白在大肠杆菌周质靶向的信号肽。
Sci Rep. 2018 May 3;8(1):6986. doi: 10.1038/s41598-018-25192-3.
7
Optimizing host cell physiology and stress avoidance for the production of recombinant human tumour necrosis factor α in Escherichia coli.优化宿主细胞生理和避免应激反应以在大肠杆菌中生产重组人肿瘤坏死因子α。
Microbiology (Reading). 2018 Apr;164(4):440-452. doi: 10.1099/mic.0.000622. Epub 2018 Feb 14.
8
Recombinant pharmaceuticals from microbial cells: a 2015 update.来自微生物细胞的重组药物:2015年最新进展
Microb Cell Fact. 2016 Feb 9;15:33. doi: 10.1186/s12934-016-0437-3.
9
Use of a stress-minimisation paradigm in high cell density fed-batch Escherichia coli fermentations to optimise recombinant protein production.在高密度补料分批大肠杆菌发酵中使用应激最小化范式来优化重组蛋白生产。
J Ind Microbiol Biotechnol. 2014 Sep;41(9):1391-404. doi: 10.1007/s10295-014-1489-1. Epub 2014 Jul 24.
10
Flow cytometric analysis of E. coli on agar plates: implications for recombinant protein production.琼脂平板上大肠杆菌的流式细胞术分析:对重组蛋白生产的影响
Biotechnol Lett. 2014 Jul;36(7):1485-94. doi: 10.1007/s10529-014-1511-8. Epub 2014 Mar 21.